|
|
Prosthetic Joint Infection After Primary Total Knee Arthroplasty: Incidence, Microbiology and Risk Factors |
| 1F32AI164809-01A1 |
|
NIAID |
2022 |
|
|
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome |
| 5R01AI141662-04 |
|
NIAID |
2022 |
|
|
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome |
| 5R01AI143710-04 |
|
NIAID |
2022 |
|
|
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome |
| 5R01AI145988-04 |
|
NIAID |
2022 |
|
|
Mediator kinases as interferon antagonists in Down Syndrome |
| 5R01AI156739-03 |
|
NIAID |
2022 |
|
|
The Impact of Maternal CMV Infection on Birth Outcomes |
| 5R03AI151426-02 |
|
NIAID |
2022 |
|
|
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome |
| 5R21AI161827-02 |
|
NIAID |
2022 |
|
|
A New Approach to Treat Prosthetic Joint Infections with a ClpP Activating Antibiotic |
| 5R44AI157081-02 |
|
NIAID |
2022 |
|
|
Defining the Role of DNA Rereplication of Chromosome 21 in the Development and Pathophysiology of Down Syndrome |
| 1 R01 AI155918-01 |
BLACK, JOSHUA CRANSTON |
NIAID |
2021 |
|
|
The Impact of Maternal CMV Infection on Birth Outcomes |
| 1 R03 AI151426-01A1 |
STOWE, RAYMOND PRESTON |
NIAID |
2021 |